At this time, posts about Celltrion Healthcare are rapidly increasing on portals and stock communities. Today, foreigners have tentatively been recorded as net buyers of 194,349 shares of Celltrion Healthcare, while institutions have net sold 5,000 shares. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.
As of 12:30 PM on the 17th, the stock price of Celltrion Healthcare is 159,700 KRW, up 0.69% from the previous day, with a trading volume of 1,921,285 shares, which is 39.79% of the 5-day average trading volume.
In addition to Celltrion Healthcare, posts by investors are also surging for Daewoong Pharmaceutical (069620), IM (101390), and Daehan Electric Wire (001440).
※ Source: AI Investment Assistant AI Lassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
